2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC2844 | |||||||||||||||||||||||
Submitter : | Mr. Wilson Shepard | Date & Time: | 02/16/2006 04:02:37 | |||||||||||||||||||||
Organization : | Mr. Wilson Shepard | |||||||||||||||||||||||
Category : | Health Professional | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
The loss of bio-identical products would be a terrible hindrance to the care of those around me. I cant believe this is even being considered. It seems that the care of patients is now out of the hands of doctors and in the hands of the drug companies. | ||||||||||||||||||||||||